Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: Ginsenoside Rb1 can ameliorate the key inflammatory cytokines TNF-α and IL-6 in a cancer cachexia mouse model

Fig. 1

Effect of WEG, GE5, GE50 and Rb1 on the tumor-free body weight in C26 tumor-bearing mice. (a, b) The body weight of each mouse in all groups was measured every two days at the same time until the twenty-third day. (a) Control (normal mice administered with PBS, n = 6), Model (tumor-bearing mice administered with PBS, n = 6), WEG (tumor-bearing mice treated with WEG, n = 6); (b) Control (normal mice administered with PBS, n = 11), Model (tumor-bearing mice administered with PBS, n = 11), GE5 (tumor-bearing mice treated with GE5, n = 10), GE50 (tumor-bearing mice treated with GE50, n = 11), and Rb1 (tumor-bearing mice treated with Rb1, n = 11). Model group vs. Control group: * P < 0.05

Back to article page